We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$56.3B
AUM Growth
+$6.14B
Cap. Flow
+$1.76B
Cap. Flow %
3.13%
Top 10 Hldgs %
15.08%
Holding
4,631
New
103
Increased
2,522
Reduced
1,306
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 8.31%
2 Financials 6.96%
3 Consumer Discretionary 5.46%
4 Healthcare 4.97%
5 Industrials 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGTC
4351
DELISTED
Applied Genetic Technologies Corporation
AGTC
$12 ﹤0.01%
3
AMR
4352
DELISTED
Alta Mesa Resources Inc
AMR
$12 ﹤0.01%
201
-16,501
-99% -$2.1K
LPCN icon
4353
Lipocine
LPCN
$17.4M
0
FLGT icon
4354
Fulgent Genetics
FLGT
$519M
$10 ﹤0.01%
1
BPTH
4355
DELISTED
Bio-Path Holdings Inc
BPTH
0
AFH
4356
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$9 ﹤0.01%
23
SSI
4357
DELISTED
Stage Stores Inc
SSI
$9 ﹤0.01%
5
ALJJ
4358
DELISTED
ALJ Regional Holdings Inc
ALJJ
$8 ﹤0.01%
6
MDLY
4359
DELISTED
Medley Management Inc
MDLY
0
CDTX
4360
DELISTED
Cidara Therapeutics
CDTX
0
SALM
4361
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$6 ﹤0.01%
4
UFAB
4362
DELISTED
Unique Fabricating, Inc.
UFAB
$6 ﹤0.01%
2
AGRX
4363
DELISTED
Agile Therapeutics
AGRX
0
APVO icon
4364
Aptevo Therapeutics
APVO
$5.46M
0
FRED
4365
DELISTED
Fred's Inc
FRED
$4 ﹤0.01%
118
-53
-31% -$18
ALIM
4366
DELISTED
Alimera Sciences
ALIM
0
NOVN
4367
DELISTED
Novan, Inc. Common Stock
NOVN
0
CEL
4368
DELISTED
Cellcom Israel, Ltd.
CEL
$3 ﹤0.01%
1
FCSC
4369
DELISTED
Fibrocell Science Inc.
FCSC
$3 ﹤0.01%
1
ALT icon
4370
Altimmune
ALT
$601M
$2 ﹤0.01%
1
CRDF icon
4371
Cardiff Oncology
CRDF
$77.8M
$2 ﹤0.01%
1
NAK
4372
Northern Dynasty Minerals
NAK
$969M
$1 ﹤0.01%
1
PSV
4373
DELISTED
Hermitage Offshore Services Ltd.
PSV
$1 ﹤0.01%
1
SMRT
4374
DELISTED
Stein Mart Inc
SMRT
$1 ﹤0.01%
1
OIBR.C
4375
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$1 ﹤0.01%
1

Similar funds

BNP Paribas Financial Markets's Q3 2019 Portfolio in Review

As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $235M trimmed.

  • BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
  • BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
  • BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
  • BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
  • BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
  • BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
  • BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.